Medicinova is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Yuichi Iwaki, with a market cap of $69.9M.
Common questions about Medicinova
Medicinova is scheduled to report earnings for Q1 2026 on May 13, 2026 after market close. Analysts estimate revenue of $127.6K.
Medicinova has approximately 13 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.